Providing Market Intelligence for 40 Years

In The News

Netflix, Inc. (NFLX): William Blair's Bull Case Points To $185 Price Target

William Blair upgraded Netflix, Inc. (NASDAQ:NFLX) to Outperform in August 2016 and believes there continues to be upside potential for the streaming video leader. Through William Blair's research, it believes that Netflix has a meaningful leg up on original programming within the over-the-top (OTT) streaming environment and suggest that these advantages might be underappreciated by investors. Moreover, contrary to some, William Blair believes OTT streaming still has plenty of room to grow both domestically and internationally, and Netflix is well positioned to benefit from this secular growth. Parks Associates estimates that more than 60% of broadband households in the United States subscribe to at least one subscription-video-on-demand (SVOD) service. William Blair believes the long-term penetration opportunity is 90% in the United States, in line with pay TV today.

From the article "Netflix, Inc. (NFLX): William Blair's Bull Case Points To $185 Price Target" by www.smartstocknews.com

Previously In The News

What’s the Best Tech Solution for Medication Management?

One perspective that the Lux study did not highlight is that of caregivers. People responsible for patient care — both now and in the future — are heavily on board with the use of mHealth tools that f...

25% Of Smartphone Owners Use Payment Apps Monthly

The report from Parks Associates found that shoppers showed a preference for retailers' mobile payment programs such as Starbucks over larger payment systems including Apple Pay, Google Wallet and And...

See Rovi at CONNECTIONS

At Rovi, we believe entertainment discovery should be simple, seamless and personal. We help consumers find content quickly by allowing them to browse, search and even speak to devices, generating rec...

TTA’s Week: Digital Health Funding, Execs’ Wish List, ActivePreventive Responds…And Theranos

We compare two major analyses of 2016 digital health funding, note a tender opportunity and an award in UK, and two more chapters of the Theranos Story. The ActiveProtective CEO responds to Reader and...